By activating GLP-1 receptors, these drugs help control appetite, food intake, and blood sugar levels, making them useful for diabetes
Table 11: Results at Week 26 in a Trial Comparing TRESIBA to Insulin Glargine U -100 in Adult Patients with Type 2 Diabetes Mellitus on OAD(s)* Study G TRESIBA Administered at the Same Time Each Day or Any Time Each Day as an Add on to One and up to Three of the Following Oral Agents Metformin, Sulfonylurea or Glinides or Pioglitazone in Adult Patients The efficacy of TRESIBA was evaluated in a 26 week randomized, open label, multicenter trial in 687 patients with type 2 diabetes mellitus inadequately controlled on basal insulin alone, oral antidiabetic agents (OADs) alone or both basal insulin and OAD
zwitterionic small molecule Purity: Manufactured to 99 % chemical purity (typical, specification-based) Appearance: Clear liquid
And questions remain about side effects, including vomiting, nausea, diarrhea, soiling the bed and weird celebrity dreams
Future discoveries may lead to a new group of obesity treatments based on probiotics, devise ways to detect developing obesity, and allow effective prevention
